FDA clears Siemens Opdima unit

Article

Siemens Medical Systems has received 510(k) clearance from the Food and Drug Administration for its Opdima digital spot mammography unit. Opdima is based on charge-coupled device (CCD) technology and retrofits to the Iselin, NJ, vendor's Mammomat 3000

Siemens Medical Systems has received 510(k) clearance from the Food and Drug Administration for its Opdima digital spot mammography unit. Opdima is based on charge-coupled device (CCD) technology and retrofits to the Iselin, NJ, vendor's Mammomat 3000 mammography system. It has a field-of-view of 49 x 85 mm, which Siemens claims is the largest in the industry among digital spot devices. Siemens launched Opdima in Europe in April (SCAN 4/30/97).

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.